Morphometric changes of the reproductive system in gilts during zearalenone mycotoxicosis;Zmiany morfometryczne układu rozrodczego loszek podczas mikotoksykozy zearalenonowej

Medycyna Weterynaryjna

Volumn 62, Issue 1, 2006, Pages 99-102

  Jakimiuk, Ewa ^a   Kuciel Lisiecka, Grazyna ^a   Zwierzchowski, Wojciech ^a   Gajȩcka, Magdalena ^a   Obremski, Kazimierz ^a   Zielonka, Łukasz ^a   Skorska Wyszyńska, Ewa ^a   Gajȩcki, Maciej ^a  

^a Wydzialu Medycyny Weterynaryjnej UWM ^*  (Poland)

Author keywords

Gilts; Zearalenone

Indexed keywords

SUS SCROFA;

EID: 33644540759     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Amsterdam A., Sasson R., Keren-Tal I., Aharoni D., Dantes A., Rimon E., Land A., Cohen T., Dor Y., Hirsh L.: Alternative pathways of ovarian apoptosis: death or life. Biochem. Pharmacol. 2003, 66, 1355-1362.
2. Bao B., Kumar N., Karp R. M., Garverick H. A., Sundaram K.: Estrogen Receptor-β Expression in Relation to the Expression of Luteinizing Hormone Receptor and Cytochrome P450 Enzymes in Rat Ovarian Follicles. Biol. Reprod. 2000, 63, 1747-1755.
3. Belstra B. A., Diekman M. A., Richert B. T., Singleton W. L.: Effects of lactation length and an exogenous progesterone and estradiol-17β regimen during embryo attachment on endogenous steroid concentrations and embryo survival in sows. Theriogenology 2002, 57, 2063-2081.
4. Benassayag C., Perrot-Applanat M. Ferre F.: Phytoestrogens as modulators of steroid action in target cells. J. Chromatogr. B 2002, 777, 233-248.
5. Diel P., Schmidt S., Vollmer G.: In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens. J. Chromatogr. B 2002, 777, 191-202.
6. Eertmans F, Dhooge W., Stuyvaert S., Comhaire F.: Endocrine disruptors: effects on male fertility and screening tools for their assessment. Toxicol. in Vitro 2003, 17, 515-524.
7. Gajȩcki M.: Zearalenone undesirable substances in feed. Pol. J. Vet. Sci. 2002, 5, 117-122.
8. Haritha S., Rajagopalan G.: Follicular growth, endometrial thickness, and serum estradiol levels in spontaneous and clomiphene citrate-induced cycles. Int. J. Gynecol. Obstet. 2003, 81, 287-292.
9. Harlow C. R., Hillier S. G.: Connective tissue growth factor in the ovarian paracrine system. Mol. Cell. Endocrinol. 2002, 187, 23-27.
10. Jóźwidk J., Podgórski J.: Statystyka od podstaw. Polskie Wydawnictwo Ekonomiczne. Warszawa 2000.
11. Korach K. S., Emmen J. M. A., Walker V. R., Hewitt S. C., Yates M., Hall J. M., Swope D. L., Harrel J. C., Couse J. F.: Update on animal models developed for analyses of estrogen receptor biological activity. J. Steroid. Biochem. Mol. Biol. 2003, 86, 387-391.
12. Kotwica J., Krzymowski T., Dȩbek J.: Kaniulizowanie naczyń żylnych u świń do badań endokrynologicznych. Medycyna Wet. 1978, 44, 118-120.
13. Krysiek J., Gregoraszczuk E., Milewicz T., Klimek R.: Kontrola wzrostu i atrezji pȩcherzyków jajnikowych. Gin. Prakt. 1996, 4, 39-41.
14. Madej J. A.: Estrogeny w nowotworach narza̧dów płciowych. Medycyna Wet. 2004, 60, 6-11.
15. Marsden D. E., Hacker N. F.: The classification, diagnosis and management of endometrial hyperplasia. Rev. Gynecol. Pract. 2003, 3, 89-97.
16. Mayr U., Butsch A., Schneider S.: Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 1992, 74, 135-149.
17. Mikamo E., Harada S., Nishikawa J., Nishihara T.: Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor. Toxicol. Appl. Pharmacol. 2003, 193, 66-72.
18. Mueller S. O.: Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J. Chromatogr. B 2002, 777, 155-165.
19. Mueller S., Simon S., Chae K., Metzler M., Korach K. S.: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells. Toxicol. Sci. 2004, 80, 14-25.
20. Olsen M. E., Pettersson H., Sandholm K. A., Kiessling K. C.: Quantitative liquid chromatographic method using fluorescence detection for determining zearalenone and its metabolites in blood plasma and urine. J. Assoc. Anal. 1985, 68, 632-635.
21. Ouanes Z., Ayed-Boussema I., Baati T., Creppy E. E., Bacha H.: Zearalenone induces chromosome aberrations in mouse bone marrow: preventive effect of 17-estradiol, progesterone and Vitamin E. Mutat. Res-Gen. Tox. En. 2005, 565, 139-149.
22. Ptaszyńska M.: Hormonalna regulacja cyklu owulacyjnego, cia̧zy i porodu u świņ. Medycyna Wet. 2001, 76, 641-645.
23. Rosenfeld C. S., Wagner J. S., Roberts R. M., Lubahn D. B.: Intraovarian actions of estrogen. Reproduction 2001, 122, 215-226.
24. Roulillier P., Mutton P., Dufour M., Sirard M. A., Guilbault L. A.: Steroid production, cell proliferation, and apoptosis in cultured bovine antral and mural granulose cells: development of an in vitro model to study estradiol production. Mol. Reprod. Dev. 1998, 50, 170-177.
25. Słomczyńska M.: Dynamika rozmieszczenia receptorów hormonów steroidowych w jajniku. Postȩpy Biol. Kom. 2002, 29, 27-46.
26. Słmczyńska M.: The effect of phytoestrogens on the reproductive tract. Pol. J. Vet. Sci. 2004, 7, 223-226.
27. .Slomczynska M., WozniakJ.: Differential distribution of estrogen receptor -β and estrogen receptor -α in the porcine ovary. Exp. Clin. Endocrinol. Diabetes 2001, 109, 238-244.
28. Tiemann U., Tomek W., Schneider F., Vanselow J.: Effects of mycotoxins α-and β-zearalenol on regulation of progesterone synthesis in cultured granulose cells from porcine ovaries. Reprod. Toxicol. 2003, 17, 673-681.
29. Tiemann U., Viergutz T., Jonas L., Schneider F.: Influence of the mycotoxins α- and β-zcaralenol and deoxynivalenol on the cell cycle of cultured porcine endometrial cells. Reprod. Toxicol. 2003, 17, 209-218.
30. Tkaczyk M., Kalita K:. Receptor estrogenowy-β budowa, regulacja i funkcja. Post. Biochem. 2001, 47, 72-78.